Search alternatives:
significant increased » significant increase (Expand Search), significant increases (Expand Search), significantly increased (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search)
marked decrease » marked increase (Expand Search)
increased body » increased odds (Expand Search)
Showing 1 - 20 results of 20,149 for search '(( significant ((largest decrease) OR (marked decrease)) ) OR ( significant increased body ))', query time: 0.67s Refine Results
  1. 1
    Significant increase in body temperature post-challenge.

    Significant increase in body temperature post-challenge. by Anne E. Boyer (237019)

    Published 2022
    “…<p>The threshold for a significant increase in body temperature (SIBT) is established as the mean pre-challenge (or baseline) temperature plus 2 standard deviations (SD) of the mean pre-challenge temperature. …”
    Save to List
    Saved in:
  2. 2
    The fasting-refeeding regimen increased Akt phosphorylation.

    The fasting-refeeding regimen increased Akt phosphorylation. by Tucker Hopkins (20790529)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3
    Fluid loss and hydration in CON (n = 22) and HOT (n = 17) surgeries; Decrease in body mass in kg (A), decrease in body mass in % of total body mass (B), rate of decrease in body mass (C), and U<sub>SG</sub> scores (D).

    Fluid loss and hydration in CON (n = 22) and HOT (n = 17) surgeries; Decrease in body mass in kg (A), decrease in body mass in % of total body mass (B), rate of decrease in body ma... by Zehra Palejwala (7507409)

    Published 2023
    Save to List
    Saved in:
  4. 4
    Body weight of <i>InR</i><sup>[E19]/</sup>TM2 <i>D</i>. <i>melanogaster</i> on days 10 (10D), 20 (20D), and 30 (30D) in the four groups.

    Body weight of <i>InR</i><sup>[E19]/</sup>TM2 <i>D</i>. <i>melanogaster</i> on days 10 (10D), 20 (20D), and 30 (30D) in the four groups. by Denghui Wang (10275794)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  5. 5
    Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.

    Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

    Published 2025
    Save to List
    Saved in:
  6. 6
    Schematic representation of the study protocol.

    Schematic representation of the study protocol. by Neng Pan (5262032)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 7
    Baseline characteristics.

    Baseline characteristics. by Neng Pan (5262032)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 8
    Comparison within groups.

    Comparison within groups. by Neng Pan (5262032)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    Comparison before and after the experiment in each group.

    Comparison before and after the experiment in each group. by Neng Pan (5262032)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    Data ste.

    Data ste. by Neng Pan (5262032)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 11
    Comparison of data after the experiment.

    Comparison of data after the experiment. by Neng Pan (5262032)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    Correlation diagram of each parameter in each group.

    Correlation diagram of each parameter in each group. by Neng Pan (5262032)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    Recruitment process.

    Recruitment process. by Neng Pan (5262032)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    Comparison of post-experimental outcome measures.

    Comparison of post-experimental outcome measures. by Neng Pan (5262032)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    Significantly Enriched Pathways.

    Significantly Enriched Pathways. by Jiyong Zhang (2498740)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 16
    Lifespan curves of <i>InR</i><sup>[E19]</sup>/TM2 <i>D</i>. <i>melanogaster</i> in four groups.

    Lifespan curves of <i>InR</i><sup>[E19]</sup>/TM2 <i>D</i>. <i>melanogaster</i> in four groups. by Denghui Wang (10275794)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 17
    Relative abundance of <i>Acetobacter</i>, <i>Wolbachia</i>, and <i>Lactobacillus</i> in the four groups.

    Relative abundance of <i>Acetobacter</i>, <i>Wolbachia</i>, and <i>Lactobacillus</i> in the four groups. by Denghui Wang (10275794)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  18. 18
    S1 Data -

    S1 Data - by Denghui Wang (10275794)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  19. 19
    Gut microbiota diversity indices of <i>InR</i><sup>[E19]</sup>/TM2 <i>D</i>. <i>melanogaster</i> in the four groups.

    Gut microbiota diversity indices of <i>InR</i><sup>[E19]</sup>/TM2 <i>D</i>. <i>melanogaster</i> in the four groups. by Denghui Wang (10275794)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  20. 20
    Fig 7 -

    Fig 7 - by Denghui Wang (10275794)

    Published 2022
    Subjects:
    Save to List
    Saved in:

Search Tools: